Market Pulse

Latest company updates, ordered by publication date.

Birchtech Corp.

Birchtech Secures $78 Million Patent Infringement Judgment

Event summary

  • Birchtech received a final judgment of approximately $78 million from the U.S. District Court of Delaware following a 2024 patent infringement jury verdict against several energy companies.
  • The judgment includes pre- and post-judgment interest, with additional interest accruing daily until payment.
  • Birchtech has secured nine license and/or supply agreements and received $37 million in license fees and settlements related to its patented technologies.
  • The company intends to use the funds to accelerate development of novel water purification technologies targeting PFAS contaminants.

The big picture

Birchtech’s victory represents a significant win for patent holders challenging industry incumbents, particularly in sectors facing increasing environmental scrutiny. The $78 million judgment provides a substantial war chest for the company to pursue its expansion into water purification, a market estimated to be worth billions as regulations surrounding PFAS contamination tighten. This case highlights the growing importance of intellectual property protection in specialized technology niches and the potential for litigation to reshape industry dynamics.

What we're watching

Litigation Risk
The remaining defendants in the Iowa lawsuit could challenge the judgment or seek further delays, potentially impacting the timing and amount of Birchtech’s recovery.
Technology Adoption
The pace at which utilities adopt Birchtech’s water purification technologies will determine the success of its expansion into that market and the realization of projected revenue growth.
Financial Discipline
How Birchtech manages the influx of capital from the judgment will be critical; aggressive investment in new technologies carries execution risk and could dilute existing shareholder value.
NetraMark Holdings Inc.

NetraMark Backlog Surge Signals Clinical Trial AI Adoption

Event summary

  • NetraMark’s contract backlog increased to C$2.5 million, moving the company closer to its mid-2026 target of C$8–10 million.
  • The company completed onboarding with Worldwide Clinical Trials, enabling inclusion in Phase 2 and 3 bids for CNS and Oncology trials.
  • NetraMark held a Critical Path Innovation Meeting (CPIM) with the FDA to discuss its NetraAI platform’s application in clinical trial design.
  • A peer-reviewed study highlighting NetraAI’s capabilities was accepted for publication in npj Digital Medicine, part of the Nature Portfolio.
  • NetraMark secured an Ontario Research Fund – Research Excellence (ORF-RE) Award in collaboration with the Centre for Addiction and Mental Health (CAMH).

The big picture

NetraMark’s progress reflects the broader trend of AI adoption in clinical trials, driven by the need to improve efficiency and reduce costs in drug development. The FDA’s engagement suggests a growing openness to AI-driven methodologies, but regulatory approval remains a key hurdle. The partnership with Worldwide Clinical Trials provides a crucial route to market, but also introduces dependency on a larger CRO.

What we're watching

Execution Risk
The company's ability to convert its growing backlog into revenue will be crucial, as revenue recognition is tied to project-specific timelines and data readouts.
Regulatory Headwinds
While the FDA CPIM was constructive, NetraMark’s pursuit of the MIDD Paired Meeting Program hinges on a pharmaceutical sponsor's willingness to collaborate, introducing a dependency.
Channel Dependency
NetraMark’s reliance on Worldwide Clinical Trials for market access creates a potential bottleneck; the success of this partnership will significantly impact the company’s growth trajectory.
Tidal Cyber Inc.

Tidal Cyber Award Signals Shift to Adversary-Focused Cybersecurity

Event summary

  • Tidal Cyber received 'Threat-Led Defense Company of the Year' recognition from GRC Outlook on December 18, 2025.
  • The award highlights Tidal Cyber's focus on 'Threat-Led Defense,' a strategy centered on real adversary behavior.
  • The company was founded in 2021 by former MITRE leaders Rick Gordon, Frank Duff, and Richard Struse.
  • Tidal Cyber’s platform utilizes NARC™ AI to transform threat intelligence into ATT&CK-aligned Procedures, creating Coverage Maps.

The big picture

The award from GRC Outlook underscores a growing recognition that cybersecurity is evolving beyond compliance and audit functions to become a core risk mitigation strategy. Tidal Cyber's 'Threat-Led Defense' approach, which connects security controls to real-world adversary behavior, represents a significant departure from traditional vulnerability-focused models. This shift is driven by the increasing sophistication of cyberattacks and the need for organizations to proactively defend against targeted threats.

What we're watching

Governance Dynamics
The increasing integration of GRC with proactive threat defense suggests a broader shift in corporate risk management, potentially increasing demand for specialized platforms like Tidal Cyber's.
Competitive Landscape
Given the founders' backgrounds at MITRE, Tidal Cyber's success will depend on its ability to differentiate its commercial offering from MITRE's open-source ATT&CK framework and avoid direct competition.
Adoption Rate
The effectiveness of Tidal Cyber’s approach hinges on the willingness of organizations to move beyond traditional vulnerability-centric security models and adopt a behavior-driven defense strategy, which may require significant cultural and operational changes.
Latin Metals Inc.

Latin Metals to Spin Out Copper Projects, Upsizes Concurrent Financing

Event summary

  • Latin Metals Inc. is spinning out its Para Copper and Auquis Copper projects into a new subsidiary, Latin Explore Inc.
  • A Supreme Court of British Columbia interim order has been obtained to facilitate the spin-out via a plan of arrangement.
  • A non-brokered private placement (Concurrent Financing) has been upsized to CAD $3 million, with subscription receipts priced at CAD $0.10 each.
  • Shareholders will vote on the arrangement, share exchange, and incentive plan on January 14, 2026.
  • Following the arrangement, Finco shareholders are expected to hold approximately 69% of Latin Explore shares.

The big picture

The spin-out of the Para and Auquis copper projects reflects a common strategy among junior exploration companies to unlock value by separating assets with different risk/reward profiles. The upsized financing suggests strong investor interest in Latin Explore's potential, but also highlights the capital requirements of early-stage copper exploration in Peru. The structure, with Finco taking a majority stake, indicates a pre-existing investment relationship and potentially a longer-term development plan for the projects.

What we're watching

Shareholder Approval
The success of the arrangement hinges on shareholder approval, and a failure to secure the required votes could derail the spin-out and impact Latin Metals' strategic direction.
Finco Alignment
The significant ownership stake held by Finco shareholders in Latin Explore will likely influence the new entity’s operational and strategic decisions, requiring careful management of potential conflicts of interest.
TSXV Listing
Latin Explore’s ability to secure and maintain a listing on the TSXV will depend on meeting the exchange’s requirements, including demonstrating sufficient exploration activity and financial stability.
PTC Inc.

Lamborghini Integrates PTC's PLM Suite to Accelerate Electrification

Event summary

  • Lamborghini is implementing PTC's Windchill (PLM), Codebeamer (ALM), and Creo (CAD) software suite to streamline product development.
  • The collaboration aims to improve data traceability, engineering change management, and cross-departmental collaboration at Lamborghini.
  • Lamborghini is showcasing the integrated solution at CES 2026, demonstrating a front bumper lifecycle example using AI-powered tools.
  • Lamborghini is the first super sports car brand to offer a fully hybridized lineup, including the Revuelto, Urus SE, and Temerario.

The big picture

Lamborghini's adoption of PTC's Intelligent Product Lifecycle platform underscores the increasing need for automotive manufacturers to digitally transform their development processes to accelerate electrification and meet evolving consumer demands. The move highlights the growing importance of PLM and ALM solutions in managing the complexity of modern vehicle development, particularly as software and electronics become increasingly critical components. PTC's win with a high-profile client like Lamborghini validates its strategy of integrating AI into its PLM offerings, but also puts pressure on the company to deliver on the promised benefits.

What we're watching

Integration Risk
The success of PTC's implementation hinges on Lamborghini's ability to adapt its workflows and fully adopt the new software, which could face internal resistance or require significant training.
AI Adoption
The demonstrated AI capabilities (Codebeamer AI, Windchill AI, ServiceMax AI) will need to prove tangible ROI beyond initial demonstrations to justify the investment and drive broader adoption within Lamborghini.
Competitive Response
Other luxury automotive brands will likely observe Lamborghini's experience with PTC's suite, potentially accelerating their own PLM/ALM modernization efforts and intensifying competition for PTC's services.
Novo Nordisk

Novo Nordisk Seeks FDA Approval for Combination Obesity Drug CagriSema

Event summary

  • Novo Nordisk submitted a New Drug Application (NDA) to the FDA for CagriSema, a once-weekly combination of cagrilintide and semaglutide, on December 18, 2025.
  • REDEFINE 1 trial data showed an average weight loss of 20.4% with CagriSema versus 3.0% with placebo, when evaluating the treatment effect regardless of patient adherence.
  • CagriSema combines a novel amylin analogue (cagrilintide) with semaglutide, targeting complementary obesity pathways.
  • The FDA is expected to review the application in 2026.

The big picture

Novo Nordisk's move to combine GLP-1 agonists with amylin analogues represents a strategic shift towards more comprehensive obesity treatment, moving beyond the current focus on GLP-1 RAs alone. This combination aims to address multiple pathways involved in weight regulation, potentially leading to greater efficacy. The REDEFINE trial data suggests a significant advantage over existing therapies, but the commercial success will hinge on regulatory approval and market adoption in a rapidly evolving landscape.

What we're watching

Regulatory Risk
The FDA review process could be impacted by increasing scrutiny of obesity drugs and their potential side effects, potentially delaying or impacting approval.
Market Adoption
The success of CagriSema will depend on physician and patient acceptance, which could be influenced by the drug's cost and potential gastrointestinal side effects.
Pipeline Competition
Novo Nordisk's market share in obesity treatment could be challenged by competing therapies in development, requiring continued innovation and differentiation.
Revolution Medicines, Inc.

Revolution Medicines Advances Daraxonrasib Pancreatic Cancer Trial

Event summary

  • Revolution Medicines initiated enrollment in Phase 3 trial RASolute 304, evaluating daraxonrasib in patients with resectable pancreatic ductal adenocarcinoma (PDAC) following adjuvant chemotherapy.
  • The trial aims to enroll approximately 500 patients with PDAC harboring oncogenic RAS mutations.
  • Daraxonrasib is a RAS(ON) multi-selective inhibitor, targeting mutations including G12X, G13X, and Q61X.
  • This is one of four Phase 3 trials currently evaluating daraxonrasib, with three focused on PDAC and one on non-small cell lung cancer.

The big picture

Pancreatic cancer represents a significant unmet medical need with limited treatment options and a dismal five-year survival rate of only 3%. Revolution Medicines' focus on RAS-addicted cancers, a common feature in PDAC, positions daraxonrasib as a potential breakthrough therapy. The success of RASolute 304 will be critical for validating the company's RAS(ON) inhibitor platform and its broader oncology pipeline.

What we're watching

Clinical Efficacy
The trial's primary endpoint, disease-free survival, will be a key indicator of daraxonrasib's potential to meaningfully impact PDAC outcomes, given the disease's poor prognosis.
Regulatory Pathway
Success in RASolute 304 will be crucial for Revolution Medicines to secure regulatory approval for daraxonrasib, potentially opening up a significant market opportunity in a disease with high unmet need.
Competitive Landscape
The trial's results will be compared against standard observation, and the emergence of competing RAS inhibitors could impact daraxonrasib's market share and pricing strategy.
Fusemachines Inc.

Fusemachines Bets on Retail, Real Estate for 2026 Growth

Event summary

  • Fusemachines (NASDAQ:FUSE) publicly outlined a growth strategy focused on 2026.
  • The strategy centers on four pillars: vertical product innovation, organic growth, strategic partnerships, and selective acquisitions.
  • The company is prioritizing retail and real estate as its primary vertical focus areas.
  • Fusemachines recently held an AMA session with GateWatchHQ to discuss the strategy and address investor questions.
  • The company is expanding responsible AI governance features and AI education programs.

The big picture

Fusemachines’ shift towards a focused vertical strategy, following its recent public debut, reflects a broader trend among AI-as-a-service providers to specialize and demonstrate tangible ROI to enterprise clients. The company’s emphasis on responsible AI governance also aligns with increasing regulatory scrutiny and investor demand for ethical AI practices. The company's ability to scale its AI Studio and Engines platform will be critical to achieving its growth targets.

What we're watching

Execution Risk
The success of Fusemachines’ strategy hinges on its ability to effectively execute across four distinct pillars, which could strain resources and management focus.
Vertical Traction
While retail and real estate are prioritized, the company must demonstrate sustained demand and ROI within these verticals to justify its focus and avoid spreading resources too thin.
Partnership Dynamics
The reliance on global resellers and systems integrators introduces a layer of complexity; Fusemachines’ growth will depend on the ability to cultivate and manage these partnerships effectively.
Commerce.com, Inc.

BigCommerce Integrates with Stripe's Agentic Commerce Suite to Enable AI-Driven Sales

Event summary

  • BigCommerce, a subsidiary of Commerce.com (CMRC), has integrated with Stripe’s new Agentic Commerce Suite.
  • The integration allows BigCommerce merchants to utilize AI agents for product discovery and checkout.
  • Stripe’s Agentic Commerce Suite aims to simplify AI integration, previously requiring months of bespoke engineering.
  • The suite supports agentic discovery, flexible checkout, merchant-of-record status, and fraud protection via Shared Payment Tokens (SPTs) and Stripe Radar.

The big picture

The partnership signifies a broader trend of embedding AI agents directly into the e-commerce purchase funnel, moving beyond product discovery to encompass the entire checkout process. This integration lowers the barrier to entry for merchants wanting to leverage AI, but also introduces new complexities around fraud prevention and brand control. The success of this initiative will depend on Stripe’s ability to deliver a scalable and secure platform that resonates with BigCommerce’s diverse merchant base.

What we're watching

Adoption Rate
The pace at which BigCommerce merchants adopt the Agentic Commerce Suite will indicate the true demand for AI-driven sales and Stripe’s ability to deliver on its promise of simplified integration.
Competitive Response
Other ecommerce platform providers will likely accelerate their own AI agent integrations, potentially creating a competitive landscape for both BigCommerce and Stripe.
Fraud Risk
The effectiveness of Stripe’s fraud protection measures (SPTs and Radar) in mitigating risks associated with non-human traffic will be crucial for maintaining merchant trust and avoiding financial losses.
Genius Group Limited

Genius Group Pursues ASX Dual Listing with DLA Piper Advisory

Event summary

  • Genius Group Limited (GNS) has engaged DLA Piper as advisor for a dual listing on the Australian Securities Exchange (ASX).
  • The decision follows a review of potential Asia-Pacific exchanges, including the Hong Kong Exchange (HKEX) and the Korea Exchange (KRX).
  • DLA Piper will prepare and lodge an 'In Principle Advice Application' with ASX within 45 days.
  • The dual listing process is expected to take approximately four months and is subject to ASX approval.
  • Genius Group is utilizing CHESS Depositary Interests (CDIs) to facilitate trading on the ASX for US-based investors.

The big picture

Genius Group's pursuit of a dual listing on the ASX signals a strategic effort to broaden its investor base and enhance accessibility within the Asia-Pacific region. This move aligns with a broader trend of US-listed companies seeking to tap into the growing capital markets of Asia, particularly as regional interest in AI and blockchain-related businesses continues to rise. The use of CDIs demonstrates a commitment to facilitating seamless trading for local investors, potentially unlocking significant capital inflows.

What we're watching

Regulatory Approval
The success of the dual listing hinges on ASX approval, which could be impacted by evolving regulatory frameworks for US-listed companies seeking secondary listings in Asia-Pacific markets.
CDI Adoption
The uptake of CHESS Depositary Interests (CDIs) by Asia-Pacific investors will be a key indicator of the listing’s success and the potential for increased liquidity.
Market Sentiment
Genius Group’s stock performance will be influenced by broader investor sentiment towards AI-powered education and Bitcoin-first business models in the Asia-Pacific region.
IDrive Inc.

IDrive Targets Salesforce Data Protection Gap with New Backup Service

Event summary

  • IDrive Inc. launched 'IDrive Salesforce Backup' on December 18, 2025.
  • The service provides automated cloud-to-cloud backup and granular recovery for Salesforce data and metadata.
  • Pricing is $20/user/seat/year with unlimited storage, or $2/seat/month.
  • The service supports SOC 2 Type 2, SEC, SOX, and HIPAA compliance standards.

The big picture

While Salesforce offers robust data management capabilities, it lacks comprehensive, automated backup solutions for user-side data and metadata, leaving organizations vulnerable to human error, ransomware, and configuration issues. IDrive’s entry addresses a growing need for specialized data protection within the Salesforce ecosystem, capitalizing on increasing regulatory scrutiny and the rising cost of data breaches. The $20/user/seat price point positions IDrive competitively against potentially more complex and expensive enterprise solutions.

What we're watching

Adoption Rate
The success of IDrive Salesforce Backup hinges on convincing Salesforce users, many of whom may be unaware of the data protection gap, to adopt a third-party backup solution.
Competitive Landscape
Existing Salesforce ecosystem partners and emerging data protection specialists will likely respond, potentially creating pricing pressure and requiring IDrive to differentiate its offering beyond basic functionality.
Salesforce Integration
IDrive's ability to maintain seamless integration with evolving Salesforce platforms and APIs will be critical for long-term customer retention and expansion of the service.
Avetta, LLC

Avetta's Vetify Streamlines Compliance for Electrical Contractor, Accelerating Onboarding

Event summary

  • Avetta’s Vetify service has helped Hatzel & Buehler, a commercial electrical contractor, reduce administrative time spent on compliance renewals by 50%.
  • Hatzel & Buehler, with 2,000 employees and 20+ branches, manages compliance for over 60 clients across multiple states.
  • Vetify accelerates new client onboarding for Hatzel & Buehler, shortening the process from weeks to days.
  • The solution manages COI management, documentation processing, and issue resolution, freeing up Hatzel & Buehler staff for other strategic initiatives.

The big picture

The increasing complexity of regulatory compliance and the demand for greater transparency within supply chains are driving adoption of SCRM solutions. Avetta’s Vetify offering addresses a specific pain point – the resource-intensive management of compliance documentation – and positions the company to capitalize on the growing need for specialized SCRM services within the construction sector. This highlights a broader trend of outsourcing non-core functions to specialized providers to improve operational efficiency and reduce risk.

What we're watching

Adoption Rate
The success of Avetta’s Vetify hinges on broader adoption among contractors facing increasingly complex compliance requirements; limited uptake could cap revenue growth.
Competitive Landscape
The SCRM space is becoming increasingly crowded, and Avetta must demonstrate Vetify’s differentiated value proposition to maintain its market position and fend off competitors.
Client Retention
Hatzel & Buehler’s positive experience is a strong signal, but Avetta’s ability to replicate these results across a wider client base will be crucial for long-term success and retention.
Aptiv PLC

Aptiv Partners with Vecna Robotics to Accelerate AMR Development

Event summary

  • Aptiv PLC and Vecna Robotics have entered a strategic collaboration to co-develop next-generation Autonomous Mobile Robot (AMR) solutions.
  • The partnership integrates Aptiv’s perception hardware (PULSE™ sensor) and machine learning technologies with Vecna Robotics’ autonomy and orchestration platform (CaseFlow™).
  • Aptiv will showcase Vecna Robotics’ CPJ Co-Bot Pallet Jack at CES 2026.
  • The collaboration aims to deliver cost-efficient automation at scale across industrial environments.

The big picture

The partnership reflects the growing demand for automation solutions in warehousing and manufacturing, driven by labor shortages and the need for increased efficiency. By combining Aptiv’s established perception and compute capabilities with Vecna’s AI-driven orchestration, the collaboration aims to lower the barrier to entry for AMR adoption, potentially expanding the market beyond early adopters. This move positions Aptiv to capitalize on the broader trend of Industry 4.0 and the increasing digitization of industrial processes.

What we're watching

Competitive Landscape
The success of this partnership will depend on Aptiv and Vecna’s ability to differentiate their combined offering from established AMR providers and navigate increasing competition in the industrial automation space.
Integration Risk
Integrating Aptiv’s software and compute platform with Vecna’s autonomy platform presents integration risks that could delay product launches or impact performance if not managed effectively.
Adoption Rate
The pace at which industrial customers adopt these new AMR solutions will be influenced by factors such as capital expenditure budgets and the availability of skilled labor to manage and maintain the systems.
Ernst & Young Global Limited

EY Launches Peer-Mentorship Program for State CIOs Amid Rising Public Sector Tech Challenges

Event summary

  • EY has launched the EY Government and Public Sector (GPS) Chief Information Officer (CIO) Advisor in Residence Program, effective December 18, 2025.
  • The program is an initiative of the EY Center for Government Modernization, designed to support state-level technology leaders.
  • The program leverages a CIO Advisory Council composed of former state CIOs, including Claire Bailey, James Collins, Chris Estes, Lori Victor Feller, Doug Holt, Karen Robinson, and Michael Tosh.
  • The program aims to address challenges like evolving cyber threats, budget pressures, and the complexities of governor appointments.

The big picture

State CIOs face increasing pressure to modernize IT infrastructure while navigating tight budgets and evolving security threats. EY’s program represents a recognition of the growing need for peer support and mentorship within the public sector, particularly as technology leadership transitions frequently due to political appointments. This initiative positions EY to capitalize on the demand for specialized advisory services within a market increasingly reliant on technology for citizen services.

What we're watching

Governance Dynamics
The program’s success hinges on the active participation and influence of the Advisory Council; a lack of engagement could undermine its intended impact on state CIO decision-making.
Talent Retention
Whether the program can effectively address the broader issue of talent retention within state government IT departments remains to be seen, as mentorship alone may not solve systemic workforce challenges.
EY’s Expansion
The program’s rollout and expansion to other levels of government (federal, local) will indicate the broader market demand for EY’s public sector advisory services and its strategic priorities.
Sezzle Inc.

Sezzle's Financial Literacy Program Reaches 1 Million Users

Event summary

  • Sezzle’s MoneyIQ program has reached 1 million lessons completed in its first year.
  • Over 200,000 users have engaged with the financial literacy program embedded within the Sezzle app.
  • A November 2024 survey indicated only 37% of Sezzle respondents felt confident about their finances.
  • A follow-up survey after MoneyIQ’s rollout showed 51% of users now feel “very confident” about their finances.

The big picture

Sezzle is attempting to differentiate itself within the increasingly crowded Buy Now, Pay Later market by embedding financial literacy into its core offering. This strategy addresses a genuine consumer need – a lack of financial confidence among Gen Z – and positions Sezzle as more than just a payment facilitator. The success of MoneyIQ will be a key indicator of whether this broader platform approach can drive long-term user loyalty and profitability in a sector facing growing regulatory and competitive pressures.

What we're watching

User Retention
Whether the initial surge in user confidence and engagement with MoneyIQ translates into sustained BNPL usage and reduced delinquency rates remains to be seen.
Competitive Response
Other BNPL providers will likely observe Sezzle’s success and may attempt to replicate similar financial literacy initiatives, potentially commoditizing the offering.
Regulatory Scrutiny
The integration of financial education into a BNPL platform could draw increased regulatory attention regarding the potential for misleading or manipulative practices.
PSQ Holdings, Inc.

PublicSquare Raises $7.5 Million via Registered Direct Offering

Event summary

  • PublicSquare (PSQH) entered into a definitive agreement with an existing institutional investor for a registered direct offering.
  • The offering involves 6,818,184 shares of Class A common stock (or pre-funded warrants) and warrants to purchase up to 8,522,730 shares.
  • The combined purchase price per share and warrant is $1.10, with warrants exercisable six months after issuance.
  • The offering is expected to close on December 19, 2025, and will generate approximately $7.5 million in gross proceeds.
  • Net proceeds will be used for general corporate purposes, including working capital.

The big picture

This registered direct offering provides PublicSquare with a relatively quick and inexpensive way to raise capital, avoiding the dilution of a traditional equity offering. However, the warrant component and the reliance on an existing investor suggest the company may be facing challenges in accessing capital markets at more favorable terms. The offering underscores the ongoing need for PublicSquare to demonstrate a clear path to profitability and validate its niche strategy within the competitive fintech landscape.

What we're watching

Capital Allocation
The company's stated use of proceeds for 'general corporate purposes' lacks specificity, and future disclosures will be critical to assess whether the capital is deployed effectively to drive growth or address operational challenges.
Investor Base
The fact that an *existing* institutional investor is participating suggests some level of confidence, but the size of the offering and the warrant structure may signal concerns about broader market appetite for the stock.
Values Alignment
PublicSquare's stated commitment to 'values-driven innovation' is a core part of its brand, and future product development and marketing initiatives will need to consistently reinforce this positioning to maintain investor and customer loyalty.
McFarlane Lake Mining Limited

McFarlane Lake Commences $13M Juby Gold Project Drilling Program

Event summary

  • McFarlane Lake Mining has begun a 13,000-meter exploration drilling program at its 100%-owned Juby Gold Project in Ontario.
  • The program targets expansion of known mineralization and depth/strike potential across four zones: Juby, Golden Lake, Big Dome, and Hydro Creek.
  • The initial drilling phase will focus on the 826 zone, following up on 2013 exploration results.
  • McFarlane’s Juby Gold Project currently holds a NI 43-101 compliant Mineral Resource Estimate of 4.21 million ounces of gold.
  • The drilling campaign is expected to be completed by May 2026.

The big picture

McFarlane Lake’s drilling program reflects a broader trend among junior gold miners to expand existing resources and unlock value through exploration. The company’s focus on depth and strike potential suggests a belief that the Juby project holds significant, yet unrealized, upside. The project’s location within the Abitibi Greenstone Belt, a historically prolific gold-producing region, positions McFarlane within a competitive landscape of established and emerging players.

What we're watching

Resource Validation
The success of this drilling program hinges on its ability to expand the current resource estimate and convert inferred resources to indicated categories, which will significantly impact valuation.
Geological Risk
The 826 zone follow-up drilling carries geological risk; the initial 2013 results may not be representative of the zone's overall mineralization potential.
Cost Management
Given the $13 million budget and projected May 2026 completion date, the company’s ability to manage costs and maintain operational efficiency will be critical to shareholder returns.
Domestic Metals Corp.

Domestic Metals Grants Options Ahead of Key Drilling Program

Event summary

  • Domestic Metals Corp. granted stock options totaling 2.7 million shares to directors, officers, and consultants with an exercise price of $0.25 per share, expiring December 27, 2030.
  • The company is preparing for a diamond drill program in Q1 2026 at the Smart Creek Copper Porphyry Project in Montana, a joint venture with Rio Tinto.
  • Rio Tinto has previously drilled 26 of 40 permitted sites at Smart Creek, reporting a significant intercept of 109.73 meters @ 0.75% Cu.
  • Fieldwork at the Sunrise Mine Target has identified a quartz vein stockwork with 4.26 g/t gold, advancing the target to the drill testing phase.

The big picture

Domestic Metals' progress at Smart Creek, particularly the identification of the Sunrise Mine Target, represents a potentially significant de-risking event for the company. The joint venture with Rio Tinto lends credibility to the project, but the success of the upcoming drill program will be the ultimate determinant of value. The stock option grants are a common mechanism for incentivizing management and key personnel during a period of heightened exploration activity.

What we're watching

Drill Results
The success of the Q1 2026 drill program at Smart Creek will be critical in validating the company’s geological interpretation and potentially unlocking significant copper and gold resources.
Rio Tinto Commitment
Rio Tinto’s continued investment and participation in the Smart Creek joint venture will be a key indicator of the project’s perceived potential.
Shareholder Sentiment
The stock option grants, while standard practice, may influence shareholder perception of management alignment and the company’s long-term prospects given the current share price.
Nouveau Monde Graphite Inc.

Nouveau Monde Graphite Raises $20 Million in US Equity Offering

Event summary

  • Nouveau Monde Graphite (NMG) priced an 8,333,334 share public equity offering at $2.40 per share, gross proceeds of $20 million.
  • The offering is solely for US investors and will close on or about December 19, 2025, subject to customary approvals.
  • Proceeds will fund long-lead equipment procurement, construction activities, engineering for the Matawinie Mine and Bécancour Battery Material Plant projects, and general working capital.
  • Maxim Group LLC is acting as the sole placement agent for the offering.

The big picture

This equity offering signals a continued reliance on public markets to fund Nouveau Monde Graphite’s ambitious expansion plans. The move comes as demand for graphite, a key component in electric vehicle batteries and other advanced materials, is surging, but also as the company faces the capital-intensive challenges of developing a greenfield mining and processing operation. The offering’s pricing suggests investor caution regarding the company’s execution risk and the potential for delays or cost overruns.

What we're watching

Project Execution
The successful deployment of the raised capital into the Matawinie Mine and Bécancour Battery Material Plant projects will be critical to demonstrating NMG’s operational capabilities and achieving production targets.
Share Price Volatility
The offering’s impact on NMG’s share price will depend on investor perception of the company’s growth prospects and the broader market sentiment towards graphite and battery materials.
Funding Runway
The additional $20 million will extend NMG’s funding runway, but continued access to capital markets at favorable terms will be essential for future expansion plans.
BriaCell Therapeutics Corp.

BriaCell's Immunotherapy Trial Gains Prominence in Nature Medicine

Event summary

  • BriaCell's Phase 3 Bria-IMT clinical trial for metastatic breast cancer has been featured in Nature Medicine’s ‘Eleven clinical trials that will shape medicine in 2026’.
  • The trial, known as BRIA-ABC, is evaluating BriaCell’s lead candidate, Bria-IMT, in combination with an immune checkpoint inhibitor versus physician’s choice.
  • BriaCell anticipates reporting top-line data as early as H1-2026, with interim analysis expected after 144 patient events (deaths).
  • Over 160 patients have been enrolled in the Phase 3 trial to date, screened from a pool of over 230.

The big picture

The inclusion of BriaCell’s trial in Nature Medicine highlights the ongoing need for novel therapies in metastatic breast cancer, a market with limited effective options despite significant investment. The trial’s inclusive design, while laudable, could also complicate regulatory review and market adoption. The outcome will significantly influence investor sentiment towards cell-based immunotherapies targeting difficult-to-treat cancers.

What we're watching

Clinical Efficacy
The interim analysis for overall survival (OS) will be critical; a lack of statistically significant improvement could severely impact BriaCell’s valuation and future development plans.
Regulatory Pathway
The FDA Fast Track designation suggests accelerated review potential, but the trial’s inclusive nature and real-world comparator arm may introduce complexities in the approval process.
Market Adoption
Even with approval, the trial’s focus on patients with extensive prior treatments and diverse subtypes may limit the initial market penetration and require a targeted commercialization strategy.